Active Pharmaceutical Ingredients Market to touch US$119.7 Billion by 2020: Transparency Market Research

News provided by

Feb 05, 2016, 10:30 ET

ALBANY, New York, February 5, 2016 /PRNewswire/ --

A new Transparency Market Research report states that the global active pharmaceuticals ingredients (APIs) market stood at US$119.7 bn in 2014 and is predicted to reach US$185.9 bn by 2020. It is expected to expand at a CAGR of 6.50% from 2014 to 2020. The title of the report is "Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020".

The global pharmaceutical industry has suffered enormously due to patent expiry of blockbuster drugs in the past few years. However, this has facilitated a surge in the demand for low-cost substitutes across the globe resulting in a boost to active pharmaceutical ingredient (API) manufacturing. The approvals of biosimilars in Europe has added to the total API market revenue, and the recent approval of Novartis' filgrastim biosimilar in the U.S. is expected to continue the upward trend in this market. The overall global active pharmaceutical ingredients market was valued at USD 119.7 billion in 2013 and is anticipated to reach USD 185.9 billion by 2020, expanding at a CAGR of 6.5% during the forecast period from 2014 to 2020.

Browse Industry Research Report at http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

The global active pharmaceuticals ingredients (APIs) market is driven by the rising abbreviated new drug applications (ANDA). In the past few years, the growth in ANDAs has in turn fuelled the demand for APIs. In addition to this, the growth in filing drug master files (DMFs) from several Indian firms has fueled the overall APIs market. On the other hand, the global active pharmaceuticals ingredients market will be constrained by the strict European Union regulatory policies.

As per the report, the APIs market is fuelled by the rising abbreviated new drug applications and the increasing drug master file filing via Indian companies. The prime opportunity seen in the market is the patent expiry of promising biological drugs. On the other hand, factors such as the stringent European Union regulatory policies will impede the growth of the APIs market in the coming years.

On the basis of type of manufacturing, the market is segmented into API contract manufacturing and captive or in-house API manufacturing. Amongst these, the segment of captive or in-house API manufacturing is experiencing a rapid decline in the market for APIs owing to its lack of profitability for the manufacturer and rising degree of competition in the market. Pharmaceutical companies are inclined towards API contract manufacturing rather than in-house API manufacturing owing to the increasing costs of research and development and the pressure to maintain low prices of finished goods. Thus, outsourcing of API production is increasingly being preferred by manufacturers.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

On the basis of type of API, the market is segmented into biological APIs and synthetic chemical APIs. Amongst these, the segment of biological APIs is experiencing the most significant growth rate owing to the huge number of pharmaceutical companies involved in this segment.

The chief players dominant in the market are Boehringer Ingelheim Group, Dr. Reddy's Laboratories, Ltd., Cambrex Corporation, BASF SE, Lonza Group, Hospira, Inc., Mylan, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, and Pfizer, Inc., among others.

Browse Regional Analysis: http://www.europlat.org/active-pharmaceutical-ingredients-api-market-global-industry-analysis-size-share-growth-trends-and-forecast-2014-2020.htm

The global active pharmaceutical ingredients market is segmented as follows:

Active Pharmaceutical Ingredients Market, by Type of Manufacturing

Captive or In-house API manufacturing
API contract manufacturing

Active Pharmaceutical Ingredients Market, by Type of API

Synthetic Chemical API
Biological API

Active Pharmaceutical Ingredients Market, by Type of Drug

Branded or Innovative Prescription Drugs
Generic Prescription Drugs
Over-the-counter Drugs

Active Pharmaceutical Ingredients Market, by Therapeutic Area

Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs
Musculoskeletal Drugs
Other Drugs (antibacterial, antiviral, antifungal, etc.)

Active Pharmaceutical Ingredients Market, by Geography

North America
Europe
Asia Pacific
Rest of the World (RoW)

Trending Reports:

Inhalation and Nasal Spray Generic Drugs Market:

http://www.transparencymarketresearch.com/inhalation-nasal-spray-generic-drugs.html

LATAM Adalimumab Market:

http://www.transparencymarketresearch.com/latam-adalimumab-market.html

Smoking Cessation and Nicotine De-addiction Products Market:

http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html

About Us:

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Sudip.S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/